Type 2 Diabetes Mellitus, Hypoglycemic Agents, Psychosocial Intervention, Randomized Controlled Trial
Conditions
Interventions
Experimental group (randomized controlled trial): 38 people with type 2 diabetes mellitus taking oral antidiabetics will receive the brief intervention entitled “Coping plan for difficulties in taking
Sponsors
Universidade Federal de São João Del Rei - Campus Centro Oeste Dona Lindu
Universidade Federal de São João Del Rei - Campus Centro Oeste Dona Lindu
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age 18 or over; both sexes; use of oral antidiabetics for at least six months; diagnosis of type 2 diabetes mellitus; positive intention (greater than or equal to 4) to carry out the behavior of taking oral antidiabetics; ability to read and write in Brazilian Portuguese; preserved cognitive state, assessed by means of a questionnaire containing seven pre-established questions
Exclusion criteria
Exclusion criteria: The medication is administered by a caregiver; they are using insulin to treat type 2 diabetes mellitus; they are being monitored for type 2 diabetes mellitus in a health service other than primary health care services
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in the Behavior of adherence to oral antidiabetics, evaluated by means of the Instrument for measuring behavior and intention by Januzzi, 2014, obtaining a higher score;The aim is to achieve a proportion of adherence greater than or equal to 80% and adequate care for taking oral antidiabetics. Assessed using the Global Evaluation of Medication Adherence (GEMA) by Marques et al, 2023 | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the individual biomedical parameters of each participant in the intervention group measured after the intervention, namely: glycated hemoglobin, fasting glucose, Low Density Lipoprotein and High Density Lipoprotein;When compared to the values obtained from the dosage of each participant in the control group;Improvement in the individual clinical markers of each participant in the intervention group assessed after the intervention was applied: weight, height, Body Mass Index, abdominal circumference and blood pressure; when compared to the values obtained from the assessment of each participant in the control group. | — |
Countries
Brazil
Contacts
Public ContactDanilo Trevisan
Universidade Federal de São João Del Rei - Campus Centro Oeste Dona Lindu
Outcome results
None listed